
Is this your show? Claim this page
PodCred
The people behind this show
People get invited back because someone remembered they were great.
PodCred is the verified record of who made this show. A credit here means people who were there confirmed the work.
Hosts
Who is on this show?
Think of the guest you still think about. The producer who makes the host sound smart. The editor who saves every episode. If a name is missing here, that person is invisible everywhere.
Add a creditEpisodes
49 episodesWebcast Finding the Right Rhythm: Supporting Pediatric Oncology Nurses in Longitudinal NF1 Management
In this CE Concepts recorded symposium, faculty will apply NF1 diagnostic and oncologic monitoring guidelines to support early recognition of NF1-PNs in pediatric patients. Learners will be shown how to incorporate MEK...
Webcast: Rare, Complex, and Under-Recognized: Supporting Oncology Nurses in the Care of Patients with NF1
Neurofibromatosis type 1 (NF1) is a rare, complex, and often under-recognized condition that presents significant diagnostic and management challenges, particularly for oncology nurses who play a central role in...
Evolving Paradigms in Immuno-Oncology: Optimizing Patient Care Through Innovative Delivery Approaches of Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICIs) have transformed the landscape of oncology, achieving remarkable outcomes across tumor types. As outcomes improve and focus shifts to patient-centered care, however, the burden of...
Targeting the Pathway: Evolving Roles of MEK Inhibitors in NF1-Associated PN
Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder characterized by tumor predisposition and a wide spectrum of neurologic manifestations. Among its most serious complications are plexiform...
Exploring the Horizons in Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions for New Treatment Strategies
Despite significant advances in the management of advanced or recurrent endometrial cancer (EC) - including the use of molecular classification, immune checkpoint inhibitors, and targeted therapies - delivering timely,...
Posts
No posts yet. Posts CEConversations shares on PodSubs, and what it publishes on Substack, YouTube and its own site, will show here.

Subscribe
Be on the front line of the show
Everything CEConversations sends its own people, first. Resources, announcements, behind the scenes, events, and giveaways, straight from the host. No account needed.
- The resources the host shares with subscribers
- Announcements before anyone else hears
- Behind the scenes from the team
- Events, invitations, and giveaways
- Only what the host sends, nothing else
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
















